# Zambon invests €30M to expand Fluimucil production in Vicenza, Italy

Zambon approved investments of over €30 million to expand its Vicenza plant to increase Fluimucil production from 50 million to 350 million vials per year, creating 120 jobs. The expansion is driven by an agreement with AstraZeneca to export to China.

- Type: Expansion
- Announced: 2018-11-13
- Where: Vicenza, Italy, Italy
- Value: $34.0M (30.0M EUR)
- Jobs: 120
- Starts operating: 2021
- Status: announced
- Capacity: 350 million vials per year
- Products: sterile vials of Fluimucil (mucolytic)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Zambon](https://endata.com/companies/19513.md)
- [AstraZeneca](https://endata.com/companies/35467.md) (customer)

## Sources

- [zambon.com](https://www.zambon.com/it/media/press/2018-11-13-zambon-sceglie-la-professionalita-italiana-produrre-le-fiale-sterili-di), 2018-11-13: "Abbiamo scelto lo stabilimento di Vicenza perché per soddisfare le enormi potenzialità del mercato cinese abbiamo bisogno di crescere molto rapidamente, continuando ad offrire un prodotto di alta qualità per i pazienti di tutto il mondo."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.